Study of diabetic foot progression based on the Tardivo algorithm in patients treated with PDT and/or PRF
Main Article Content
Abstract
OBJECTIVE: To apply the Tardivo Algorithm to outpatients diagnosed with diabetic foot and trophic lesions, monitor their progression and treatment, and subsequently analyze outcomes. METHOD: This prospective study assessed patients diagnosed with diabetic foot during outpatient visits and classified them according to the score obtained with the Tardivo Algorithm. Patients underwent serial reassessments and were reclassified according to the Tardivo Algorithm at each visit. They were followed for one year to assess possible outcomes: minor amputation, major amputation, healing wound, or complete healing, as well as the need for limb revascularization. RESULTS: During the study, one patient died and one was lost to follow-up. Among study participants, 23 achieved complete wound healing, five were in the final stage of wound healing, nine showed wound improvement, and three showed worsening. Accordingly, 23 patients were discharged from treatment, 15 remained under follow-up, and two underwent major amputation. CONCLUSION: These findings indicate that algorithms are extremely important and effective for guiding and implementing treatment. This tool can guide more appropriate care by determining the number of sessions, the technique used, the interval between sessions, and even helping to avoid indiscriminate use of resources. The successful outcomes may be associated with treatment adjustments guided by the algorithm, which allowed care to be tailored to each patient’s needs and lesion severity.
Downloads
Download data is not yet available.
Article Details
How to Cite
Caetano, P. S. S., Evangelista, E. F., Moia, B. B., & Correia, J. A. (2026). Study of diabetic foot progression based on the Tardivo algorithm in patients treated with PDT and/or PRF. ABCS Health Sciences, 50(Suppl.), e0251002. https://doi.org/10.7322/2025comuabc50.cli02
Section
COMUABC

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY) that allows others to share and adapt the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.